Investigating the molecular mechanisms of Fuzheng Yiliu Shenji prescription in SH-SY5Y neuroblastoma cells

BackgroundNeuroblastoma is the most common extracranial solid tumor in childhood. Fuzheng Yiliu Shenji Prescription (FYSP) has shown potential in treating malignant pediatric tumors in clinical settings. This study aims to explore the molecular mechanisms behind its effects, specifically in the cont...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Xueying Zhu, Yinchu Si, Cong Gai, Zhong Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-09-01
Subjects:	Fuzheng Yiliu Shenji Prescription Neuroblastoma SH-SY5Y Network pharmacology PI3K-Akt signaling pathway
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1447666/full